Nora Henrikson, PhD, MPH

Nora Henrikson

"I believe that our members are the key to helping us know how to deliver the best care possible."

Nora Henrikson, PhD, MPH

Assistant Investigator, Kaiser Permanente Washington Health Research Institute

Twitter: @norahenrikson

Biography

Nora Henrikson, PhD, MPH, conducts research that seeks to improve the lives of people with cancer and their families. Her current projects include interventions to mitigate cancer-related financial hardship and to improve communication with families about genetic risk. In addition, she leads KPWA’s participation in the Kaiser Permanente Evidence-Based Practice Center.

Dr. Henrikson joined Kaiser Permanente Washington Health Research Institute as a research associate in 2010.

RESEARCH INTERESTS AND EXPERIENCE

  • Behavioral Science

    Social/behavioral quantitative and qualitative research; intervention design; systematic review and evidence synthesis; epidemiology; patient-provider communication

  • Cancer

    Genetic testing for cancer risk, cancer-related financial hardship

  • Social Determinants of Health

    Financial hardship

  • Public Health Genetics

    Social, ethical, and policy implications of genomics and precision health

  •  

Recent publications

Lynch JA, Sharp RR, Aufox SA, Bland ST, Blout C, Bowen DJ, Buchanan AH, Halverson C, Harr M, Hebbring SJ, Henrikson N, Hoell C, Holm IA, Jarvik G, Kullo IJ, Kochan DC, Larson EB, Lazzeri A, Leppig KA, Madden J, Marasa M, Myers MF, Peterson J, Prows CA, Kulchak Rahm A, Ralston J, Milo Rasouly H, Scrol A, Smith ME, Sturm A, Stuttgen K, Wiesner G, Williams MS, Wynn J, Williams JL. Understanding the return of genomic sequencing results process: content review of participant summary letters in the eMERGE Research Network. J Pers Med. 2020;10(2):E38. doi: 10.3390/jpm10020038. PubMed

Pisu M, Banegas MP, Liang MI, Tuzzio L, Henrikson NB. How, when, and with whom should cost of care conversations occur? preferences of two distinct cancer survivor groups. JCO Oncol Pract. 2020 May 7:JOP1900726. doi: 10.1200/JOP.19.00726. [Epub ahead of print]. PubMed

Wiesner GL, Kulchak Rahm A, Appelbaum P, Aufox S, Bland ST, Blout CL, Christensen KD, Chung WK, Clayton EW, Green RC, Harr MH, Henrikson N, Hoell C, Holm IA, Jarvik GP, Kullo IJ, Lammers PE, Larson EB, Lindor NM, Marasa M, F Myers M, Peterson JF, Prows CA, Ralston JD, Milo Rasouly H, Sharp RR, Smith ME, Van Driest SL, Williams JL, Williams MS, Wynn J, Leppig KA. Returning results in the genomic era: initial experiences of the eMERGE Network. J Pers Med. 2020;10(2). pii: jpm10020030. doi: 10.3390/jpm10020030. PubMed

Opel DJ, Henrikson NB, Lepere K, Robinson JD. Progress in evidence-based communication about childhood vaccines. Acad Pediatr. 2020 Feb 10. pii: S1876-2859(20)30061-9. doi: 10.1016/j.acap.2020.02.007. [Epub ahead of print]. PubMed

Parchman ML, Palazzo L, Austin BT, Blasi P, Henrikson NB, Gundersen G, Ganos E. Taking action to address medical overuse: common challenges and facilitators. Am J Med. 2020 Feb 4. pii: S0002-9343(20)30052-8. doi: 10.1016/j.amjmed.2020.01.001. [Epub ahead of print]. PubMed

Henrikson NB, Blasi P, Dorsey CN, Mettert KD, Nguyen MB, Walsh-Bailey CL, Macuiba JA, Gottlieb LM, Lewis CC. Psychometric and pragmatic properties of social risk assessment tools in clinical settings: a systematic review. Am J Prev Med. Vol 57, Issue 6, Supp 1, p S13-S24. Dec 2019. https://doi.org/10.1016/j.amepre.2019.07.012.

Henrikson NB, Blasi PR, Dorsey CN, Mettert KD, Nguyen MB, Walsh-Bailey C, Macuiba J, Gottlieb LM, Lewis CC. Psychometric and pragmatic properties of social risk screening tools: a systematic review. Am J Prev Med. 2019 Dec;57(6 Suppl 1):S13-S24. doi: 10.1016/j.amepre.2019.07.012. PubMed

Naber SK, Kundu S, Kuntz KM, Dotson WD, Williams MS, Zauber AG, Calonge N, Zallen DT, Ganiats TG, Webber EM, Goddard KAB, Henrikson NB, van Ballegooijen M, Janssens ACJW, Lansdorp-Vogelaar I. Cost-effectiveness of risk-stratified colorectal cancer screening based on polygenic risk: current status and future potential. JNCI Cancer Spectr. 2019 Oct 14;4(1):pkz086. doi: 10.1093/jncics/pkz086. eCollection 2020 Feb. PubMed

Opel DJ, Henrikson N, Lepere K, Hawkes R, Zhou C, Dunn J, Taylor JA. Previsit screening for parental vaccine hesitancy: a cluster randomized trial.  Pediatrics. 2019 Nov;144(5). pii: e20190802. doi: 10.1542/peds.2019-0802. Epub 2019 Oct 9. PubMed

Henrikson NB, Aiello Bowles EJ, Blasi PR, Morrison CC, Nguyen M, Pillarisetty VG, Lin JS. Screening for pancreatic cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2019;322(5):445-454. doi: 10.1001/jama.2019.6190. PubMed

 

profile

Nora-Hendrikson-family_1col.jpg

Why does Nora Henrikson study patients’ cost of treatment?

Dr. Henrikson’s Annals of Internal Medicine study describes 3 kinds of cost concerns that can affect cancer care.

video

Hendrikson-Nora-Cost-of-Care-ORCA_1col.jpg

Discussing patients’ concerns about cost of care

Nora Henrikson discusses her latest research published in the Annals of Internal Medicine in May 2019. (Vimeo, 3:50)

KPWHRI IN THE MEDIA

Cost-of-care conversations: How can health care be more transparent?

Avalere podcast, Feb. 22, 2019

health services & economics

Tuzzio-Leah_1col.jpg

Community health workers can help make the difference for patients

Leah Tuzzio, MPH, and colleagues describe an underutilized role that can help primary care become truly patient-centered.